These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19859641)

  • 1. Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism.
    Vestergaard P; Schwartz K; Pinholt EM; Rejnmark L; Mosekilde L
    Osteoporos Int; 2010 Sep; 21(9):1591-7. PubMed ID: 19859641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene.
    Vestergaard P; Schwartz F; Rejnmark L; Mosekilde L
    Osteoporos Int; 2011 Mar; 22(3):993-1001. PubMed ID: 21165600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke in relation to use of raloxifene and other drugs against osteoporosis.
    Vestergaard P; Schwartz K; Pinholt EM; Rejnmark L; Mosekilde L
    Osteoporos Int; 2011 Apr; 22(4):1037-45. PubMed ID: 20449570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England.
    Osborne V; Layton D; Perrio M; Wilton L; Shakir SA
    Drug Saf; 2010 Jul; 33(7):579-91. PubMed ID: 20553059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
    Martín-Merino E; Petersen I; Hawley S; Álvarez-Gutierrez A; Khalid S; Llorente-Garcia A; Delmestri A; Javaid MK; Van Staa TP; Judge A; Cooper C; Prieto-Alhambra D
    Osteoporos Int; 2018 Feb; 29(2):467-478. PubMed ID: 29199359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta-analysis.
    Adomaityte J; Farooq M; Qayyum R
    Thromb Haemost; 2008 Feb; 99(2):338-42. PubMed ID: 18278183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of atrial fibrillation associated with use of bisphosphonates and other drugs against osteoporosis: a cohort study.
    Vestergaard P; Schwartz K; Pinholt EM; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2010 May; 86(5):335-42. PubMed ID: 20309678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal tolerability and patterns of switching in patients treated for primary osteoporosis: the Swedish Adherence Register Analysis (SARA).
    Landfeldt E; Lang A; Robbins S; Ström O
    Calcif Tissue Int; 2011 Sep; 89(3):234-45. PubMed ID: 21695544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure in patients treated with bisphosphonates.
    Grove EL; Abrahamsen B; Vestergaard P
    J Intern Med; 2013 Oct; 274(4):342-50. PubMed ID: 23679231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric and esophagus events before and during treatment of osteoporosis.
    Vestergaard P; Schwartz K; Pinholt EM; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2010 Feb; 86(2):110-5. PubMed ID: 19957165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk of venous thromboembolism among Taiwan osteoporotic fracture population under osteoporosis pharmacological treatments.
    Lin TC; Lee CH; Yang CY; Yang YH; Lin SJ
    J Clin Endocrinol Metab; 2014 May; 99(5):1599-607. PubMed ID: 24606074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of oral bisphosphonates and risk of venous thromboembolism: a population-based case-control study.
    Lamberg AL; Horvath-Puho E; Christensen S; Sørensen HT
    Osteoporos Int; 2010 Nov; 21(11):1911-7. PubMed ID: 19997902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of gastrointestinal cancer in users of bisphosphonates and other antiresorptive drugs against osteoporosis.
    Vestergaard P
    Calcif Tissue Int; 2011 Dec; 89(6):434-41. PubMed ID: 22002678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of bisphosphonates and risk of breast cancer.
    Vestergaard P; Fischer L; Mele M; Mosekilde L; Christiansen P
    Calcif Tissue Int; 2011 Apr; 88(4):255-62. PubMed ID: 21253712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones?
    Vestergaard P
    Calcif Tissue Int; 2012 Jan; 90(1):22-9. PubMed ID: 22120197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronate.
    Lu PY; Hsieh CF; Tsai YW; Huang WF
    Clin Ther; 2011 Sep; 33(9):1173-9. PubMed ID: 21849210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of strontium ranelate and risk of acute coronary syndrome: cohort study.
    Svanström H; Pasternak B; Hviid A
    Ann Rheum Dis; 2014 Jun; 73(6):1037-43. PubMed ID: 24651624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study.
    Vestergaard P; Schwartz K; Rejnmark L; Mosekilde L; Pinholt EM
    J Oral Maxillofac Surg; 2012 Apr; 70(4):821-9. PubMed ID: 21764202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic venous thromboembolism following fractures distal to the knee: a nationwide Danish cohort study.
    Wahlsten LR; Eckardt H; Lyngbæk S; Jensen PF; Fosbøl EL; Torp-Pedersen C; Gislason GH; Olesen JB
    J Bone Joint Surg Am; 2015 Mar; 97(6):470-7. PubMed ID: 25788303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
    Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
    Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.